In support of the above results, KEGG pathway enrichment revealed that the molecular mechanism underlying ALS/PDC may be related to oxidative phosphorylation of mitochondria, ribosomes, and the synaptic vesicle cycle. The gene discussed is PDC; the disease is amyotrophic lateral sclerosis.